BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15113995)

  • 1. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients.
    Wei JC; Tsai WC; Lin HS; Tsai CY; Chou CT
    Rheumatology (Oxford); 2004 Jul; 43(7):839-42. PubMed ID: 15113995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis.
    van Gaalen FA; Verduijn W; Roelen DL; Böhringer S; Huizinga TW; van der Heijde DM; Toes RE
    Ann Rheum Dis; 2013 Jun; 72(6):974-8. PubMed ID: 22887649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between HLA-B60 and HLA-B27 as a Better Predictor of Ankylosing Spondylitis in a Taiwanese Population.
    Wei JC; Sung-Ching HW; Hsu YW; Wen YF; Wang WC; Wong RH; Lu HF; Gaalen FA; Chang WC
    PLoS One; 2015; 10(10):e0137189. PubMed ID: 26469786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis.
    Maksymowych WP; Tao S; Vaile J; Suarez-Almazor M; Ramos-Remus C; Russell AS
    J Rheumatol; 2000 Jan; 27(1):183-9. PubMed ID: 10648037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.
    Brown MA; Pile KD; Kennedy LG; Calin A; Darke C; Bell J; Wordsworth BP; Cornélis F
    Ann Rheum Dis; 1996 Apr; 55(4):268-70. PubMed ID: 8733445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience.
    Hou TY; Chen HC; Chen CH; Chang DM; Liu FC; Lai JH
    Intern Med J; 2007 Nov; 37(11):749-52. PubMed ID: 17908086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
    Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA
    Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA alleles and HLA-B27 haplotypes associated with susceptibility and severity of ankylosing spondylitis in a Portuguese population.
    Pimentel-Santos FM; Matos M; Ligeiro D; Mourão AF; Ribeiro C; Costa J; Santos H; Barcelos A; Pinto P; Cruz M; Sousa E; Santos RA; Fonseca JE; Trindade H; Guedes-Pinto H; Branco JC;
    Tissue Antigens; 2013 Dec; 82(6):374-9. PubMed ID: 24498993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27,B44.
    Purrmann J; Zeidler H; Bertrams J; Juli E; Cleveland S; Berges W; Gemsa R; Specker C; Reis HE
    J Rheumatol; 1988 Nov; 15(11):1658-61. PubMed ID: 3266250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals.
    Höhler T; Schäper T; Schneider PM; Meyer zum Büschenfelde KH; Märker-Hermann E
    Arthritis Rheum; 1998 Aug; 41(8):1489-92. PubMed ID: 9704649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies.
    Vargas-Alarcón G; Garcia A; Bahena S; Melin-Aldana H; Andrade F; Ibañez-de-Kasep G; Alcocer-Varela J; Alarcón-Segovia D; Granados J
    Ann Rheum Dis; 1994 Nov; 53(11):755-8. PubMed ID: 7826137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankylosing spondylitis without B27: no evidence for gene conversion.
    Pease CT; Ellis SA; McMichael AJ; Brewerton DA
    Ann Rheum Dis; 1988 Dec; 47(12):1001-3. PubMed ID: 3264696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of monoclonal antibodies for flow cytometric analysis of HLA-B27 antigen.
    Ward AM; Nikaein A
    Cytometry; 1995 Mar; 22(1):65-9. PubMed ID: 7587736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
    Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27 negative ankylosing spondylitis in a father and a son.
    Skomsvoll JF; Ostensen M; Romberg O; Anda S
    Scand J Rheumatol; 1995; 24(5):321-2. PubMed ID: 8533051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of HLA-B*2706 in Taiwanese patients with ankylosing spondylitis.
    Chen IH; Yang KL; Lee A; Huang HH; Lin PY; Lee TD
    Eur J Immunogenet; 2002 Oct; 29(5):435-8. PubMed ID: 12358855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of flow cytometry for HLA B27 phenotyping: study of a HLA B7/HLA B27 double marker technique].
    Ulrich G
    Allerg Immunol (Paris); 1997 Jan; 29(1):11-4. PubMed ID: 9213414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of HLA-Bw62 and Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis.
    Wagener P; Zeidler H; Eckert G; Deicher H
    Z Rheumatol; 1984; 43(5):253-7. PubMed ID: 6335328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of HLA genes in HLA-B27 positive ankylosing spondylitis and HLA-B27 positive peripheral reactive arthritis.
    Westman P; Leirisalo-Repo M; Partanen J; Koskimies S
    Arthritis Rheum; 1996 Jun; 39(6):943-9. PubMed ID: 8651988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An HLA-B27 negative case of ankylosing spondylitis with acute iridocyclitis].
    Yoshikawa M; Nakamura S; Ohno S
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):271-5. PubMed ID: 1558026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.